In addition, as the highest gene with mutational frequency in pan-can, TOP2A mutations have been proven to correlate with cancer progression and drug resistance in a variety of tumor types, including breast cancer [31], glioblastoma [32]and cervical cancer [33]. Here, TOP2A is linked to neoplasm.